Keywords
How to Cite
Abstract
Leptin acts as a regulating hormone in the maternal fetal interface. We demonstrated that leptin promotes proliferation and survival of trophoblastic cells. Moreover, leptin prevents cellular stress under hypoxic condition in trophoblastic cells. In this sense, Leptin is incremented in different pathologies associated to pregnancies like as preeclampsia. In this work we aimed to elucidate the mechanisms involved in Leptin antiapoptotic effect on placental apoptosis induced by cobalt chloride (CoCl2). This agent stabilizes HIF-1α transcription factor. We used Swan-71 cells, a cytotrophoblast human cell line and human term placental explants cultured under normoxia and hypoxia conditions. Swan-71 cells and placental explants were treated with CoCl2 (50 or 100 µM) in presence or absence of leptin (100 ng/ml). The expression of HIF-1α, p53, Caspase-3, cPARP and Mdm2 was determined by Western blot or Immunofluorescence (IF). Apoptosis was determined by the visualization of apoptotic nuclei by IF. All procedures were approved by ethical review committee at the Alejandro Posadas National Hospital.
We observed that HIF-1α stabilization increased apoptosis in Swan-71 cells. Treatment with CoCl2 increased PARP-1 and Caspase-3 levels indicating that apoptosis was induced. Leptin treatment diminished this effect. Moreover, p53 protein expression and nuclear localization was enhanced by hypoxic condition. Leptin was capable to regulate p53 pathway, increasing Mdm2 expression, a p53 negative regulator. All these results suggest that HIF-1α stabilization enhances placental apoptosis and leptin is capable to protect these cells under hypoxia conditions.
[2] N.G. Than, R. Romero, A.L. Tarca, K.A. Kekesi, Y. Xu, Z. Xu, K. Juhasz, G. Bhatti, R.J. Leavitt, Z. Gelencser, J. Palhalmi, T.H. Chung, B.A. Gyorffy, L. Orosz, A. Demeter, A. Szecsi, E. Hunyadi-Gulyas, Z. Darula, A. Simor, K. Eder, S. Szabo, V. Topping, H. El-Azzamy, C. LaJeunesse, A. Balogh, G. Szalai, S. Land, O. Torok, Z. Dong, I. Kovalszky, A. Falus, H. Meiri, S. Draghici, S.S. Hassan, T. Chaiworapongsa, M. Krispin, M. Knofler, O. Erez, G.J. Burton, C.J. Kim, G. Juhasz, Z. Papp, Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia, Frontiers in immunology 9 (2018) 1661.
[3] M.P. Magarinos, V. Sanchez-Margalet, M. Kotler, J.C. Calvo, C.L. Varone, Leptin promotes cell proliferation and survival of trophoblastic cells, Biol Reprod 76(2) (2007) 203-10.
[4] A.R. Toro, A. Perez-Perez, I. Corrales Gutierrez, V. Sanchez-Margalet, C.L. Varone, Mechanisms involved in p53 downregulation by leptin in trophoblastic cells, Placenta 36(11) (2015) 1266-75.
[5] A.R. Toro, J.L. Maymo, F.M. Ibarbalz, A. Perez-Perez, B. Maskin, A.G. Faletti, V. Sanchez-Margalet, C.L. Varone, Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation, PLoS One 9(6) (2014) e99187.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.